Tag Archive > Target

WAZ: Rüdiger Nehberg: "Grenzregion zwischen Äthiopien und Eritrea ist unsicher"

Essen (ots) – Der Abenteurer und Äthiopien-Experte Rüdiger Nehberg weist nach dem Überfall auf europäische Touristen an der Grenze zu Eritrea auf die Gefährlichkeit dieser Grenzregion hin: “Es gibt Banditen dort, manche kommen aus Eritrea, und es gibt Verstecke, die nur schwer aufzuspüren sind”, sagte Nehberg den NRW-Titeln der WAZ-Mediengruppe (Donnerstagsausgaben). Nehberg weiter: ” Wir, [...]

Continue reading

, , , , , , , , , , ,

Obzerv Technologies Inc. receives a Contract from Bharat Electronics Ltd. for 46 Range-Gated Cameras

Quebec City (ots/PRNewswire) – Obzerv Technologies Inc. has received a contract from Bharat Electronics Ltd. to supply 46 ARGC-2400 cameras. Obzerv’s electro-optic cameras will be integrated by Bangalore-based defense Public Sector Company Bharat Electronics Ltd. (BEL) in a multi sensors Coastal Surveillance System. Each system to be supplied to Indian Coastguard will include: the ARGC-2400, [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Azure Dynamics and RøhneSelmer Target Up To 400 Transit Connect Electric Van Sales Annually in Norway

Oak Park, Michigan (ots/PRNewswire) – – Azure Dynamics and RøhneSelmer, Ford Motor Company’s market leading dealer in Norway, sign a “Letter of Intent” to sell up to 400 Transit Connect Electric vans annually – RøhneSelmer has placed 158 orders in its first nine months as a Transit Connect Electric dealership and sees continued strong demand [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Pieris Presents Preclinical Data for PRS-080 Hepcidin Antagonist Anticalin® Program at ASH Annual Meeting

San Diego, CA, USA (ots) – Breadth of Pharmacokinetic Data Points to Tunable Half-life for Platform Pieris AG presented novel preclinical in vitro and in vivo data for its PRS-080 Anticalin hepcidin antagonist in an oral presentation at the American Society of Hematology Annual Meeting, the company announced today. In a presentation entitled “Discovery and [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Nissan Accelerates Roll Out of EV Quick Charge Network in Europe

Rolle, Switzerland, November 8 (ots/PRNewswire) – – 400 quick chargers to be given away free by Nissan – Installation in high profile locations starting February 2012 – Charge to 80% in 30 minutes Nissan is accelerating plans for a European-wide Quick Charge (QC) network for electric vehicles by giving 400 new quick charging stations free [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

EANS-Adhoc: init innovation in traffic systems AG / Higher result despite increased risks – long-term growth opportunities intact

——————————————————————————– ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– 9-month report 31.10.2011 Karlsruhe, 31st October 2011. While general economic risks increased noticeably in Q3 2011, init innovation in traffic systems AG [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

EUROCALIN Consortium Initiates EU Grant Funded Collaboration to Develop Novel Anticalin Therapeutic to Treat Anemia

Freising, Germany (ots) – – Consortium Will Receive Six Million Euro from Seventh Framework Programme The EUROCALIN Consortium, comprising 10 companies and universities from across Europe, has initiated a collaboration focused on attaining and completing initial clinical development of a novel Anticalin® therapeutic. The project will be funded in large part by the European Commission [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

EANS-News: Intercell AG / Intercell receives positive scientific advice from EMA for Pseudomonas vaccine Phase II/III-study

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Research & Development Wien (euro adhoc) – (Austria), October 12, 2011 – Today Intercell AG (VSE: ICLL) announced that it has received positive Scientific Advice from the European Medicines Agency (EMA) regarding the planned Phase II/III [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

EANS-News: Tantalus Rare Earths AG / Update on work progress and new results from Target 1, 3, 4 and 5 (with document)

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/RESOURCE ESTIMATE Düsseldorf (euro adhoc) – Tantalus Rare Earths AG (Duesseldorf, 12 October 2011,Tantalus Rare Earths AG) The Directors of Tantalus Rare Earths AG (“TRE”), a German company exploring an extensive area of secondary rare [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

EANS-News: ANDRITZ: sales of over 4 billion EUR expected for 2011, increase to more than 4.5 billion EUR planned for 2012

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information Graz (euro adhoc) – Graz, October 5, 2011. At the ANDRITZ Capital Market Days 2011, Wolfgang Leitner, President and CEO of ANDRITZ AG, today specified the sales and earnings targets of the ANDRITZ GROUP [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Anale Inkontinenz darf kein Schamthema sein / 3T-Behandlung" bietet hochwirksame Therapie

Hamburg (ots) – Anale Inkontinenz darf kein Schamthema sein “3T-Behandlung” bietet hochwirksame Therapie Weitaus mehr Menschen als vermutet leiden unter einem schwachen Darmverschluss. In neueren Schätzungen geht man davon aus, dass bis zu 5% aller Männer und Frauen -annähernd 4 Millionen Menschen in Deutschland- davon betroffen sind. Den meisten Menschen ist ein schwacher Darmverschluss unangenehm [...]

Continue reading

, , , , , , , , , , , ,

EANS-Adhoc: Atrium European Real Estate Limited / ATRIUM COMPLETES THE E191 MILLION ACQUISITION OF PALÁC FLÓRA IN PRAGUE

——————————————————————————– ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– 27.09.2011 ATRIUM COMPLETES THE E191 MILLION ACQUISITION OF PALÁC FLÓRA IN PRAGUE -Czech portfolio reaches 98 properties after Prague’s largest real estate transaction in 2011- Jersey, 27 September 2011. [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Ingenuity gibt Einführung zusätzlicher neuer MicroRNA-Inhalte zur Vervollständigung des fortschrittlichen MicroRNA-Filtersystems in IPA bekannt

Redwood City, Kalifornien (ots/PRNewswire) – – Neue experimentell erprobte miRecords-Inhalte ergänzen leistungsstarke Target-Priorisierung des microRNA-Target-Filters von IPA. Ingenuity(R) Systems, führender Anbieter von Informationslösungen für Wissenschaftler aus den Biowissenschaften, hat heute bekannt gegeben, dass neue bereits erprobte microRNA-mRNA-Target-Wechselwirkungen von miRecords [http://mirecords.biolead.org ] eingeführt wurden, dazu Tausende von zusätzlichen miRNA-mRNA-Wechselwirkungen, die manuell mithilfe zusätzlicher Peer-Review-Literatur editiert wurden. [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Johnson Controls’ ie:3 concept car makes its European debut / Vehicle demonstrates innovation in seating, electronics, interiors and batteries (mit Bild)

The ie:3 demonstrator vehicle features Johnson Controls-Saft?s next generation electric battery system with a target 100 mile range per charge. The unique, self-contained electric battery pack easily integrates into the floor of the ie:3. Picture is free of charge for editorial use – please quote the source: Johnson Controls Automotive Experience

Continue reading

, , , , , , , , , , , , , ,

More Patients with Type 2 Diabetes Reach HbA[1c] Target with Apidra® on top of Lantus® Than with Twice-daily Aspart Premixed Insulin

Paris (ots/PRNewswire) – – First Randomized Controlled Trial to Show That Basal Plus Regimen Provides more Effective Glycemic Control with Less Hypoglycemia Than with Aspart Premixed Insulin Sanofi announced today data presented at the 47th Annual Meeting of the European Association for the Study of Diabetes to show that adding mealtime Apidra(R) (insulin glulisine) to [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

prev posts